Publications by authors named "Dmitry Vlodavets"

Claim this Profile
C
Confirmatory long-term efficacy and safety results of ataluren in patients with nmDMD from Study 041, an international, randomized, double-blind, placebo-controlled, Phase III trial.
Dmitry Vlodavets, Shiwen Wu, Anna Kostera-Pruszczyk, Jong-Hee Chae, Sheffali Gulati

J Comp Eff Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Balanced Translocations Involving the Gene as a Cause of Muscular Dystrophy in Female Children: A Description of Three Cases.
Ekaterina O Vorontsova, Aysylu Murtazina, Elena Zinina, Alexander V Polyakov, Maria Sumina, Dmitry Vlodavets

Int J Mol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risdiplam in Presymptomatic Spinal Muscular Atrophy.
Richard S Finkel, Laurent Servais, Dmitry Vlodavets, Edmar Zanoteli, Maria Mazurkiewicz-Bełdzińska

N Engl J Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot Program of Newborn Screening for 5q Spinal Muscular Atrophy in the Russian Federation.
Kristina Mikhalchuk, Olga Shchagina, Alena Chukhrova, Viktoria Zabnenkova, Polina Chausova, Dmitry Vlodavets

Int J Neonatal Screen· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial.
Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, Kristy Rose, Laurent Servais, Hui Xiong, Dmitry Vlodavets

Lancet Neurol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of Type 1 spinal muscular atrophy: a retrospective, global, multicenter study.
Claude Cances, Dmitry Vlodavets, Giacomo Pietro Comi, Riccardo Masson, Maria Mazurkiewicz-Bełdzińska

Orphanet J Rare Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls.
Basil T Darras, Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, Kristy Rose, Hui Xiong, Dmitry Vlodavets

N Engl J Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnicity-related DMD Genotype Landscapes in European and Non-European Countries.
Rita Selvatici, Rachele Rossi, Fernanda Fortunato, Cecilia Trabanelli, Yamina Sifi, Dmitry Vlodavets

Neurol Genet· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human gene.
Tatiana V Egorova, Evgenia D Zotova, Denis A Reshetov, Anna V Polikarpova, Svetlana G Vassilieva, Dmitry V Vlodavets

Dis Model Mech· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI in sarcoglycanopathies: a large international cohort study.
Giorgio Tasca, Mauro Monforte, Jordi Díaz-Manera, Giacomo Brisca, Claudio Semplicini, Dmitry Vlodavets

J Neurol Neurosurg Psychiatry· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials.
Pierre G Carlier, Benjamin Marty, Olivier Scheidegger, Paulo Loureiro de Sousa, Pierre-Yves Baudin, Dmitry Vlodavets

J Neuromuscul Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis